| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |